US ex­pects to soon run out of gov­ern­ment Covid-19 funds for vac­cines, treat­ments

The US gov­ern­ment is sound­ing the alarm that com­ing up lat­er this year and in 2023, it won’t be able to pay for Covid-19 vac­cines, treat­ments and pro­phy­lac­tics mov­ing for­ward, and these prod­ucts will tran­si­tion to the com­mer­cial mar­ket.

While the US will dole out about 170 mil­lion of the up­com­ing bi­va­lent boost­ers for free this fall and win­ter, start­ing as ear­ly as Jan­u­ary 2023, the Biden ad­min­is­tra­tion an­tic­i­pates “no longer hav­ing fed­er­al funds to pur­chase or dis­trib­ute vac­cines and will need to tran­si­tion these ac­tiv­i­ties to the com­mer­cial mar­ket,” Dawn O’Con­nell, HHS’ as­sis­tant sec­re­tary for pre­pared­ness and re­sponse, wrote in a blog post yes­ter­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER